On Monday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) was -4.53% drop from the session before settling in for the closing price of $11.49. A 52-week range for SPRY has been $6.66 – $18.90.
When this article was written, the company’s average yearly earnings per share was at -2235.42%. With a float of $59.73 million, this company’s outstanding shares have now reached $98.84 million.
ARS Pharmaceuticals Inc (SPRY) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ARS Pharmaceuticals Inc stocks. The insider ownership of ARS Pharmaceuticals Inc is 39.57%, while institutional ownership is 63.76%. The most recent insider transaction that took place on Nov 13 ’25, was worth 190,050. In this transaction Chief Operating Officer of this company sold 21,828 shares at a rate of $8.71, taking the stock ownership to the 10,789 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Chief Business Officer sold 166,380 for $8.87, making the entire transaction worth $1,476,147. This insider now owns 0 shares in total.
ARS Pharmaceuticals Inc (SPRY) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.51 earnings per share (EPS) during the time that was better than consensus figure (set at -0.12) by 0.63. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
You can see what ARS Pharmaceuticals Inc (SPRY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
The latest stats from [ARS Pharmaceuticals Inc, SPRY] show that its last 5-days average volume of 1.45 million was inferior to 1.67 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 66.84%.
During the past 100 days, ARS Pharmaceuticals Inc’s (SPRY) raw stochastic average was set at 43.14%, which indicates a significant decrease from 53.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.64 in the past 14 days, which was lower than the 0.67 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.54, while its 200-day Moving Average is $12.80. Now, the first resistance to watch is $11.54. This is followed by the second major resistance level at $12.12. The third major resistance level sits at $12.41. If the price goes on to break the first support level at $10.67, it is likely to go to the next support level at $10.38. The third support level lies at $9.80 if the price breaches the second support level.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Key Stats
There are 98,849K outstanding shares of the company, which has a market capitalization of 1.08 billion. As of now, sales total 89,150 K while income totals 8,000 K. Its latest quarter income was 32,500 K while its last quarter net income were -51,150 K.
